LOC100506281: A Drug Target / Disease Biomarker (G100506281)
LOC100506281: A Drug Target / Disease Biomarker
LOC100506281 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the LOC100 family of proteins, which are known for their role in intracellular signaling. LOC100506281 has been identified as a potential drug target due to its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
One of the key functions of LOC100506281 is its role in intracellular signaling. This protein is known to play a role in the regulation of cell signaling pathways, including the TGF-β pathway. TGF-β is a well-known signaling pathway that is involved in the development and maintenance of tissues, and it is thought to be involved in the development of many diseases, including cancer.
In addition to its role in intracellular signaling, LOC100506281 is also involved in the regulation of cellular processes that are important for the survival and survival of cells. For example, LOC100506281 has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die and are removed from the body.
The potential drug target status of LOC100506281 is due to its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. LOC100506281 has been shown to be involved in the development and progression of several types of cancer, including breast, ovarian, and prostate cancer.
In addition to its involvement in cancer, LOC100506281 is also thought to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the development of progressive neurodegeneration.
LOC100506281 is also involved in the regulation of autoimmune disorders, which are conditions in which the immune system becomes abnormally active and causes inflammation and damage to the body's tissues. Examples of autoimmune disorders include rheumatoid arthritis, lupus, and multiple sclerosis.
The potential drug target status of LOC100506281 is due to its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of LOC100506281 in these conditions and to develop effective treatments.
Protein Name: Uncharacterized LOC100506281
The "LOC100506281 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100506281 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474 | LOC100506499 | LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770 | LOC101060017 | LOC101060106 | LOC101060179 | LOC101060400 | LOC101060445 | LOC101060524 | LOC101060632 | LOC101448202 | LOC101593348 | LOC101926887 | LOC101926948 | LOC101926953 | LOC101926959 | LOC101926969 | LOC101927002 | LOC101927020 | LOC101927025 | LOC101927026 | LOC101927040 | LOC101927053 | LOC101927060 | LOC101927066 | LOC101927082 | LOC101927108 | LOC101927143 | LOC101927164 | LOC101927166 | LOC101927169 | LOC101927179 | LOC101927188 | LOC101927199 | LOC101927216 | LOC101927243 | LOC101927245 | LOC101927253 | LOC101927263 | LOC101927269 | LOC101927314 | LOC101927369 | LOC101927394 | LOC101927421 | LOC101927476 | LOC101927483 | LOC101927495 | LOC101927518 | LOC101927531 | LOC101927548 | LOC101927550 | LOC101927571
